January 26: Short Courses
January 27-29: Conference
DIA's Pharmacovigilance and Risk Management Strategies Conference provides the strongest context, background, updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies that cannot be found in any other meeting. The content of this event is developed by top experts from the biopharmaceutical industry and global regulatory agencies, and DIA will convene the best speakers from around the world to discuss the current challenges and issues that matter most to professionals working in the field.
This conference will give you the foundation for strong strategic planning and practical decision-making in your pharmacovigilance programs, rather than the cookbook approaches often presented elsewhere. In addition to new developments and updates on regional regulations and guidelines, regulators from the US, EU, and other global regions provide the context and thinking behind evolving requirements.
While we work diligently to get the 2020 agenda on the web, check out our !
program from the 2019 event to get an idea of what’s to come!
As an MD with over 15 years of experience in drug safety and pharmacovigilance, I found the meeting one of the best in the industry. – Previous Attendee
This conference provides current and forward thinking thoughts on pharmacovigilance and risk management. It also provides an opportunity to meet colleagues from around the world in this field. – Previous Attendee
Who should attend?
Professionals with intermediate to advanced knowledge of, and experience in, clinical safety and who are involved in:
- Drug Safety/Pharmacovigilance
- Risk Management, including Risk Evaluation and Mitigation Strategies (REMS)
- Benefit-risk assessment and communication
- Medical Product Safety Assessment
- Regulatory Affairs
- Clinical Research
- Post-market studies and Real World Evidence generation
- Customer Engagement Programs, including Patient Support Programs
- Medical Information, Medical Communications
- Health Outcomes
It is also designed for professionals who work for:
- Industry: pharmaceuticals, biologics, combination products, devices
- Clinical Research Organizations
- Academic Research Centers
- Regulatory Agencies